Abstract:Colorectal cancer (CRC) represents a significant challenge in oncology, with increasing incidence and mortality rates worldwide, particularly among younger adults. Despite advancements in treatment modalities, the urgent need for more effective therapies persists. Immunotherapy has emerged as a beacon of hope, offering the potential for improved outcomes and quality of life. This review delves into the critical interplay between ferroptosis, an iron-dependent form of regulated cell death, and immunotherapy within the CRC context. Ferroptosis's influence extends beyond tumor cell fate, reshaping the tumor microenvironment (TME) to enhance immunotherapy's efficacy. Investigations into Ferroptosis-related Genes (OFRGs) reveal their pivotal role in modulating immune cell infiltration and TME composition, closely correlating with tumor responsiveness to immunotherapy. The integration of ferroptosis inducers with immunotherapeutic strategies, particularly through novel approaches like ferrotherapy and targeted co-delivery systems, showcases promising avenues for augmenting treatment efficacy. Furthermore, the expression patterns of OFRGs offer novel prognostic tools, potentially guiding personalized and precision therapy in CRC. This review underscores the emerging paradigm of leveraging ferroptosis to bolster immunotherapy's impact, highlighting the need for further research to translate these insights into clinical advancements. Through a deeper understanding of the ferroptosis-immunotherapy nexus, new therapeutic strategies can be developed, promising enhanced efficacy and broader applicability in CRC treatment, ultimately improving patient outcomes and quality of life in the face of this formidable disease.

The Emerging Role of Ferroptosis in EBV-Associated Cancer: Implications for Cancer Therapy

Emerging roles of ferroptosis in the tumor immune landscape: from danger signals to anti-tumor immunity

Ferroptosis in lymphoma: Emerging mechanisms and a novel therapeutic approach

Emerging Therapeutic Approaches Targeting Ferroptosis in Cancer: Focus on Immunotherapy and Nanotechnology

Ferroptosis and its emerging role in tumor

The role of ferroptosis in esophageal cancer

Emerging role of ferroptosis in glioblastoma: Therapeutic opportunities and challenges

Role of ferroptosis in esophageal cancer and corresponding immunotherapy

Emerging mechanisms and targeted therapy of ferroptosis in cancer

Emerging role of tumor microenvironmental nutrients and metabolic molecules in ferroptosis: Mechanisms and clinical implications

The Pivotal Role of Ferroptosis in Modulating the Tumor Microenvironment

Ferroptosis in cancer immunity and immunotherapy: Multifaceted interplay and clinical implications

Emerging Mechanisms and Targeted Therapy of Ferroptosis in Neurological Diseases and Neuro-oncology

Ferroptosis-Mediated Formation of Tumor-Promoting Immune Microenvironment

Recent advances of ferroptosis in tumor: From biological function to clinical application

Emerging mechanisms of ferroptosis and its implications in lung cancer

Exploring Ferroptosis-Inducing Therapies for Cancer Treatment: Challenges and Opportunities

The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions

Ferroptosis as a potential target for cancer therapy

Mechanisms of Ferroptosis and Application to Head and Neck Squamous Cell Carcinoma Treatments

Emerging Roles of Ferroptosis in Glioma